首页 / 资讯详情
OpenAI acquires Orchestra Bio
摘要
OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.
本站为资讯聚合平台，仅展示标题与摘要，原文版权归原发布方所有；如有侵权请联系我们删除。